Literature DB >> 2458104

Molecular cloning and characterization of novel prostate antigen cDNA's.

P H Riegman1, P Klaassen, J A van der Korput, J C Romijn, J Trapman.   

Abstract

Three different prostate antigen cDNA's were isolated from a PC 82 prostate tumor cDNA library. PA 75 has a size of 1.4 kb and contains the almost complete information for the 35 kD prostate antigen preproprotein. The 1.6 kb PA 525 cDNA lacks about 0.2 kb of the 3'-non coding region and contains an additional internal 0.4 kb fragment as a result of alternative splicing. PA 424 represents a 0.6 kb variant of PA 75. It contains a 0.15 kb internal fragment and a poly(A) tail preceded by an AAGAAA motive at the 3'-end. The predicted protein products of PA 525 and PA 424 will be different from PA 75 at the C-terminal end. In RNA preparations of two human prostate tumors (PC 82 and PC EW) seven different prostate antigen transcripts can be detected ranging in size from 0.5 kb to 5.6 kb. PA 75 cDNA represents the major 1.5 kb mRNA. PA 424 correlates with a 0.9 kb transcript and PA 525 with a 1.9 kb mRNA species.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458104     DOI: 10.1016/s0006-291x(88)81066-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.

Authors:  C Wei; R A Willis; B R Tilton; R J Looney; E M Lord; R K Barth; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue.

Authors:  H Yu; E P Diamandis; M Levesque; M Giai; R Roagna; R Ponzone; P Sismondi; M Monne; C M Croce
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  A novel protease homolog differentially expressed in breast and ovarian cancer.

Authors:  A Anisowicz; G Sotiropoulou; G Stenman; S C Mok; R Sager
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

4.  Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.

Authors:  A Ylikoski; M Karp; K Pettersson; H Lilja; T Lövgren
Journal:  J Mol Diagn       Date:  2001-08       Impact factor: 5.568

5.  Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.

Authors:  M P Gallee; E Visser-de Jong; J A van der Korput; T H van der Kwast; F J ten Kate; F H Schroeder; J Trapman
Journal:  Urol Res       Date:  1990

6.  A structural model for the prostate disease marker, human prostate-specific antigen.

Authors:  B O Villoutreix; E D Getzoff; J H Griffin
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

7.  Prostate specific antigen--a new constituent of breast cyst fluid.

Authors:  E P Diamandis; H Yu; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

Authors:  N Zarghami; L Grass; E P Diamandis
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Analysis of prostate-specific antigen transcripts in chimpanzees, cynomolgus monkeys, baboons, and African green monkeys.

Authors:  James N Mubiru; Alice S Yang; Christian Olsen; Sudhir Nayak; Carolina B Livi; Edward J Dick; Michael Owston; Magdalena Garcia-Forey; Robert E Shade; Jeffrey Rogers
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.